Factor | Liver infarction (+) (n = 8) | Liver infarction (−) (n = 23) | p value |
---|---|---|---|
Age (years) | 61.5 (42–78) | 65.0 (39–80) | 0.428 |
Gender, male/female | 5/3 | 16/7 | 1.000 |
CEA (ng/mL) | 4.0 (1.0–14.0) | 3.3 (0.7–493.0) | 0.519 |
CA19-9 (U/mL) | 401.0 (3.3–16,860.0) | 235.5 (0.1–3211.0) | 0.075 |
Tumor size (MDCT) (cm) | 5.0 (1.7–10.1) | 3.0 (1.7–7.4) | 0.021 |
GDA/PHA contact (MDCT), yes/no | 6/2 | 4/19 | 0.006 |
Anomaly, yes/no | 3/5 | 9/14 | 1.000 |
Neoadjuvant chemotherapy, yes/no | 7/1 | 17/6 | 0.642 |
Preoperative coil embolization, yes/no | 7/1 | 16/7 | 0.642 |
Duration since coiling to operation (days) | 15.0 (4–87) | 22.5 (4–104) | 0.203 |
Operative time (min) | 434 (313–584) | 298 (175–540) | 0.005 |
Blood loss (g) | 2130 (365–5455) | 1100 (305–10270) | 0.448 |
Blood trans fusion, yes/no | 5/3 | 12/11 | 0.698 |
Portal vein resection, yes/no | 7/1 | 9/14 | 0.037 |
Gastrectomy, yes/no | 3/5 | 2/21 | 0.093 |
Bile duct resection, yes/no | 1/7 | 0/23 | 0.258 |
Postoperative portal vein stenosis, yes/no | 5/3 | 6/17 | 0.095 |
GDA/PHA stenosis, yes/no | 8/0 | 3/20 | < 0.001 |
Tumor size (specimen) (cm) | 5.6 (2.8–10.0) | 4.0 (2.0–6.5) | 0.022 |
Histologic type, well/mod./por./other | 3/2/2/1 | 7/12/2/2 | 0.505 |
Lymph node metastasis, yes/no | 7/1 | 17/6 | 0.642 |
Arterial invasion, yes/no | 5/3 | 9/14 | 0.413 |
Portal vein invasion, yes/no | 6/2 | 15/8 | 1.000 |
Perineural invasion, yes/no | 7/1 | 22/1 | 0.456 |
Residual tumor status, R0/R1, 2 | 4/4 | 9/14 | 0.689 |
UICC stage (7th edition), IIA/IIB, III, IV | 0/8 | 6/17 | 0.298 |
Morbidity*, C–D I, II/C–D III, IV, V | 1/7 | 9/14 | 0.222 |
Pancreatic fistula**, None, grade A/grade b, C | 3/5 | 11/12 | 0.698 |
Liver abscess, yes, no | 1/7 | 0/23 | 0.258 |
Postoperative hospital stay (days) | 47.5 (26–182) | 34.0 (16–97) | 0.037 |